Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prolylcarboxypeptidase inhibitors

Prolylcarboxypeptidase inhibitors

US Patent 9365539 · Granted Jun 14, 2016

Estimated economic value: $59,713,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for treating conditions associated with NLRP activity2025
Composition and methods for MRNA vaccines against novel omicron coronavirus infe2025
Compositions and methods of mRNA vaccines against novel coronavirus infection2025
Compounds and compositions for treating conditions associated with NLRP activity2024
Compounds and compositions for treating conditions associated with NLRP activity2024
Composition and method of mRNA vaccines against novel coronavirus infection2024
Treating subterranean formations using salt tolerant superabsorbent polymer part2023
Compounds and compositions for treating conditions associated with NLRP activity2023
Sulphonamides and compositions thereof for treating conditions associated with N2023
Controlling the formation of polymer-metal complexes in wellbore operations2023
Substituted alkanolamine scale inhibitor2022
Compounds and compositions for treating conditions associated with NLRP activity2022